Cargando…
CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study)
BACKGROUND: 8–28% of patients infected with COVID-19 have evidence of cardiac injury, and this is associated with an adverse prognosis. The cardiovascular mechanisms of injury are poorly understood and speculative. We aim to use multimodality cardiac imaging including cardiac magnetic resonance (CMR...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106368/ https://www.ncbi.nlm.nih.gov/pubmed/33964872 http://dx.doi.org/10.1186/s12872-021-02027-0 |
_version_ | 1783689763760373760 |
---|---|
author | Alam, Shirjel R. Shah, Anoop S. V. Ombati, Kevin O. Nganga, Edward Gitau, Samuel Makhdomi, Khalid Chung, Michael H. Vinayak, Sudhir |
author_facet | Alam, Shirjel R. Shah, Anoop S. V. Ombati, Kevin O. Nganga, Edward Gitau, Samuel Makhdomi, Khalid Chung, Michael H. Vinayak, Sudhir |
author_sort | Alam, Shirjel R. |
collection | PubMed |
description | BACKGROUND: 8–28% of patients infected with COVID-19 have evidence of cardiac injury, and this is associated with an adverse prognosis. The cardiovascular mechanisms of injury are poorly understood and speculative. We aim to use multimodality cardiac imaging including cardiac magnetic resonance (CMR) imaging, computed tomography coronary angiography (CTCA) and positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-d-glucose integrated with computed tomography (18F-FDG-PET/CT) to identify the cardiac pathophysiological mechanisms related to COVID-19 infections. METHODS: This is a single-centre exploratory observational study aiming to recruit 50 patients with COVID-19 infection who will undergo cardiac biomarker sampling. Of these, 30 patients will undergo combined CTCA and 18F-FDG-PET/CT, followed by CMR. Prevalence of obstructive and non-obstructive atherosclerotic coronary disease will be assessed using CTCA. CMR will be used to identify and characterise myocardial disease including presence of cardiac dysfunction, myocardial fibrosis, myocardial oedema and myocardial infarction. 18F-FDG-PET/CT will identify vascular and cardiac inflammation. Primary endpoint will be the presence of cardiovascular pathology and the association with troponin levels. DISCUSSION: The results of the study will identify the presence and modality of cardiac injury associated COVID-19 infection, and the utility of multi-modality imaging in diagnosing such injury. This will further inform clinical decision making during the pandemic. Trial Registration: This study has been retrospectively registered at the ISRCTN registry (ID ISRCTN12154994) on 14th August 2020. Accessible at https://www.isrctn.com/ISRCTN12154994 |
format | Online Article Text |
id | pubmed-8106368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81063682021-05-10 CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study) Alam, Shirjel R. Shah, Anoop S. V. Ombati, Kevin O. Nganga, Edward Gitau, Samuel Makhdomi, Khalid Chung, Michael H. Vinayak, Sudhir BMC Cardiovasc Disord Study Protocol BACKGROUND: 8–28% of patients infected with COVID-19 have evidence of cardiac injury, and this is associated with an adverse prognosis. The cardiovascular mechanisms of injury are poorly understood and speculative. We aim to use multimodality cardiac imaging including cardiac magnetic resonance (CMR) imaging, computed tomography coronary angiography (CTCA) and positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-d-glucose integrated with computed tomography (18F-FDG-PET/CT) to identify the cardiac pathophysiological mechanisms related to COVID-19 infections. METHODS: This is a single-centre exploratory observational study aiming to recruit 50 patients with COVID-19 infection who will undergo cardiac biomarker sampling. Of these, 30 patients will undergo combined CTCA and 18F-FDG-PET/CT, followed by CMR. Prevalence of obstructive and non-obstructive atherosclerotic coronary disease will be assessed using CTCA. CMR will be used to identify and characterise myocardial disease including presence of cardiac dysfunction, myocardial fibrosis, myocardial oedema and myocardial infarction. 18F-FDG-PET/CT will identify vascular and cardiac inflammation. Primary endpoint will be the presence of cardiovascular pathology and the association with troponin levels. DISCUSSION: The results of the study will identify the presence and modality of cardiac injury associated COVID-19 infection, and the utility of multi-modality imaging in diagnosing such injury. This will further inform clinical decision making during the pandemic. Trial Registration: This study has been retrospectively registered at the ISRCTN registry (ID ISRCTN12154994) on 14th August 2020. Accessible at https://www.isrctn.com/ISRCTN12154994 BioMed Central 2021-05-08 /pmc/articles/PMC8106368/ /pubmed/33964872 http://dx.doi.org/10.1186/s12872-021-02027-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Alam, Shirjel R. Shah, Anoop S. V. Ombati, Kevin O. Nganga, Edward Gitau, Samuel Makhdomi, Khalid Chung, Michael H. Vinayak, Sudhir CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study) |
title | CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study) |
title_full | CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study) |
title_fullStr | CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study) |
title_full_unstemmed | CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study) |
title_short | CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study) |
title_sort | cardiovascular mechanisms in covid-19: methodology of a prospective observational multimodality imaging study (cosmic-19 study) |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106368/ https://www.ncbi.nlm.nih.gov/pubmed/33964872 http://dx.doi.org/10.1186/s12872-021-02027-0 |
work_keys_str_mv | AT alamshirjelr cardiovascularmechanismsincovid19methodologyofaprospectiveobservationalmultimodalityimagingstudycosmic19study AT shahanoopsv cardiovascularmechanismsincovid19methodologyofaprospectiveobservationalmultimodalityimagingstudycosmic19study AT ombatikevino cardiovascularmechanismsincovid19methodologyofaprospectiveobservationalmultimodalityimagingstudycosmic19study AT ngangaedward cardiovascularmechanismsincovid19methodologyofaprospectiveobservationalmultimodalityimagingstudycosmic19study AT gitausamuel cardiovascularmechanismsincovid19methodologyofaprospectiveobservationalmultimodalityimagingstudycosmic19study AT makhdomikhalid cardiovascularmechanismsincovid19methodologyofaprospectiveobservationalmultimodalityimagingstudycosmic19study AT chungmichaelh cardiovascularmechanismsincovid19methodologyofaprospectiveobservationalmultimodalityimagingstudycosmic19study AT vinayaksudhir cardiovascularmechanismsincovid19methodologyofaprospectiveobservationalmultimodalityimagingstudycosmic19study |